| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Senior Vice President | Senior Vice President
2 companies
Brynelsen Charles serves as a Director at COCH and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 3 sells. Those positions are worth an estimated $5.7M at current prices.
Historically, Brynelsen Charles's trades have earned a below-average insider score of 36/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -26.3%.
The biggest single holding is ABT (~$5.3M) as Senior Vice President. The recent filings there lean toward selling, a net 3,785 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | COCH Envoy Medical, Inc. | Director | Buy | 1,000,000 | $0.40 | $400,000.00 | +2,000% | +25.5% | - | |
| May 27, 2025 | COCH Envoy Medical, Inc. | Director | Buy | 50,000 | $1.65 | $82,402.70 | New | -28.2% | -54.6% | |
| Mar 1, 2021 | ABT Abbott Laboratories | Senior Vice President | Sell | 1,002 | $120.61 | $120,851.22 | -2.2% | -13.1% | -1.9% | |
| Mar 2, 2020 | ABT Abbott Laboratories | Senior Vice President | Sell | 1,781 | $77.89 | $138,722.09 | -3.8% | - | - | |
| Mar 1, 2019 | ABT Abbott Laboratories | Senior Vice President | Sell | 1,002 | $78.00 | $78,156.00 | -2.4% | - | - |